A multi-center trial is to commence of the innovative diagnosis device developed by Israel’s Exalenz Bioscience to detect liver disease.  The device is already used to examine a patient’s breath in order to detect bacteria in the stomach that causes ulcers.

http://www.globes.co.il/en/article-exalenz-bioscience-starts-liver-trial-1000979820